Anagenics Statistics
Want to see AU:AN1 full AI Analyst Report?
Anagenics (AN1) Stock Statistics & Valuation Metrics
Total Valuation
Anagenics has a market cap or net worth of AUD 6.90M. The enterprise value is AUD 6.04M.
- Market Cap
- AUD 6.90M
- Enterprise Value
- AUD 6.04M
Share Statistics
Anagenics has 985,450,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 985,450,800
- Owned by Insiders
- 1.23%
- Owned by Institutions
- ―
Financial Efficiency
Anagenics ’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 14.79%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 14.79%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 469.06K
- Profits Per Employee
- 28.04K
- Employee Count
- 11
- Asset Turnover
- 1.09
- Inventory Turnover
- 2.28
Valuation Ratios
The current PE Ratio of Anagenics is 15.00. Anagenics ’s PEG ratio is 0.03.
- PE Ratio
- 15.00
- PS Ratio
- 1.15
- PB Ratio
- 1.17
- Price to FCF
- -5.40
- Price to Operating Cash Flow
- -4.62
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, Anagenics had revenue of 5.16M and earned 308.47K in profits. Earnings per share was 0.00.
- Revenue
- 5.16M
- Gross Profit
- 2.81M
- Operating Income
- 629.83K
- Pretax Income
- 308.47K
- Net Income
- 308.47K
- EBITDA
- 816.06K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -1.07M and capital expenditures -24,947, giving a free cash flow of -1.09M billion.
- Operating Cash Flow
- -1.07M
- Free Cash Flow
- -1.09M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Anagenics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -18.51%
- Earnings Yield
- 6.25%
Stock Price Statistics
- Beta
- 1.27
- 52-Week Price Change
- ―
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Anagenics upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Anagenics as a current ratio of 5.27, with Debt / Equity ratio of 0.79%
- Current Ratio
- 5.27
- Quick Ratio
- 3.30
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.67
- Interest Coverage Ratio
- 9.11
Taxes
In the past 12 months, Anagenics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Anagenics EV to EBITDA ratio is 6.58, with an EV/FCF ratio of -4.91.
- EV to Sales
- 1.04
- EV to EBITDA
- 6.58
- EV to Free Cash Flow
- -4.91
- EV to Operating Cash Flow
- -5.02
Balance Sheet
Anagenics has AUD 577.43K in cash and marketable securities with AUD 33.19K in debt, giving a net cash position of AUD 544.24K billion.
- Cash & Marketable Securities
- AUD 577.43K
- Total Debt
- AUD 33.19K
- Net Cash
- AUD 544.24K
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is 54.54%, with operating margin of 12.21%, and net profit margin of 5.98%.
- Gross Margin
- 54.54%
- Operating Margin
- 12.21%
- Pretax Margin
- 5.98%
- Net Profit Margin
- 5.98%
- EBITDA Margin
- 15.82%
- EBIT Margin
- 12.21%
Analyst Forecast
The average price target for Anagenics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.83%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 5
- AI Score
- 53

